methoxy-morpholinyl-doxorubicin has been researched along with Leukemia L 1210 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Belvedere, G; Broggini, M; D'Incalci, M; Geroni, C; Grandi, M; Pennella, G; Pesenti, E; Tagliabue, G | 1 |
| Ballinari, D; Capolongo, L; Grandi, M; Pastori, A; Ripamonti, M; Spreafico, F; Suarato, A | 1 |
1 review(s) available for methoxy-morpholinyl-doxorubicin and Leukemia L 1210
| Article | Year |
|---|---|
[New anthracyclines and multidrug resistance].
Topics: Animals; Breast Neoplasms; Doxorubicin; Drug Evaluation; Drug Resistance; Humans; Leukemia; Leukemia L1210; Mice; Neoplasms, Experimental; Structure-Activity Relationship; Tumor Cells, Cultured | 1991 |
1 other study(ies) available for methoxy-morpholinyl-doxorubicin and Leukemia L 1210
| Article | Year |
|---|---|
L1210 cells selected for resistance to methoxymorpholinyl doxorubicin appear specifically resistant to this class of morpholinyl derivatives.
Topics: Animals; DNA, Neoplasm; Doxorubicin; Drug Resistance; Female; Glutathione; Leukemia L1210; Mice; Mice, Inbred DBA; Mice, Inbred Strains; Tumor Cells, Cultured | 1994 |